Morgan Stanley lowered its price target on Nike (NYSE:NKE) to $61 from $70 while maintaining an Equal Weight rating, citing a lengthening path to recovery amid macroeconomic pressures and underwhelming brand momentum.
The firm noted that recent tariff developments and broader economic conditions are likely to delay Nike’s turnaround efforts. Adding to the cautious outlook, Morgan Stanley reported limited positive feedback from wholesale partners regarding consumer demand or upcoming product innovations. Additionally, the brand’s visibility and momentum—often referred to as “brand heat”—showed no meaningful improvement over the past three months.
Analysts now believe consensus estimates for fiscal 2026 earnings may be too optimistic, and management could be forced to temper expectations of a post–fourth quarter rebound. While Nike’s strategic execution appears to be gaining some initial traction based on wholesale and specialty retail checks, the broader recovery remains both slow and unpredictable.
Complicating the narrative is Nike’s elevated valuation—trading at 32 times earnings versus its pre-COVID average of 24—making it harder for investors to justify a near-term bet on a turnaround. Still, Morgan Stanley acknowledges that expectations are currently low heading into the next earnings report, leaving room for any positive surprises to act as short-term catalysts.
